Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    21073974 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)
Conditions: Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Follicular Lymphoma
Interventions: Drug: Cyclophosphamide and Rituximab;   Drug: Filgrastim;   Radiation: Chemotherapy or Radiation therapy;   Drug: Non-myeloablative Conditioning regimen;   Procedure: Allogeneic transplant;   Procedure: Autologous transplant;   Drug: Rituximab maintenance therapy;   Drug: GVHD Prophylaxis

Study has passed its completion date and status has not been verified in more than two years.